All News

More than 500,000 clinicians using Epocrates? drug reference software will now have access to Caremark Pharmacy Services division formulary information.

Materials and computers from the University of Georgia College of Pharmacy and the offices and home of professor Flynn Warren Jr., M.S., have been seized by U.S. marshals investigating cheating on the North American Pharmacist Licensure Examination (NAPLEX).

A study conducted by the University of Wisconsin found that 4% of chronic pain patients taking opioid drugs such as OxyContin (oxycodone HCI, Purdue Pharma) or Percocet (oxycodone HCI/acetaminophen, Endo Labs) abuse the medications.

Community pharmacies are smarting over a proposed rule by HHS that will help limit the Medicare program's risk by requiring all suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) to provide CMS with a surety bond.

The Office of the Inspector General (OIG) found that the average sale price based on data reported to Medicare for 39 medications exceeded the average manufacturer price by at least 5%.

Consumers may not be aware of the May recall of Complete MoisturePlus Multipurpose Contact Lens Solution manufactured by Advanced Medical Optics (AMO) and continue to use the recalled product. Several cases of Acanthamoeba keratitis reported to CDC involved the use of AMO Complete MoisturePlus after the recall was announced.

Women with irritable bowel syndrome with constipation and chronic idiopathic constipation who are younger than 55 and meet specific guidelines may now be able to access tegaserod under a treatment investigational new drug protocol.

Privigen is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.

CDC has launched its Preteen Vaccine campaign to inform parents of its recommendations for three vaccines in this age group, mainly the 11- and 12-year-olds.

NACDS has mobilized its Rapid Response Program to take issue with a recent article in the legal publication, the West Virginia Record.

The academy explained that these sections would disadvantage Medicare beneficiaries because they would prevent Part D drug plan sponsors from using recognized PBM expertise in their development of formularies.

Prosecutors charged Valdes with conspiring with the owners of Med-Pro Billing and Unimed Pharmacy to refer patients to them in exchange for half of what Medicare paid for compounded aerosol medications.

NCPA and NACDS joined to strongly back a new bill aimed at stopping the implementation of the new Medicaid AMP rule.